|
|
|
|
Nanogram (ng) |
| A unit of weight consisting of one billionth of a gram (1 x 10-9 g). |
|
Necrosis |
| Death, usually referring to cell death. |
|
NEL |
| No Effect Level. A quantity of a substance that is below the threshold on the dose-response curve. |
|
Neonates |
| Newborn animals. |
|
Neoplasm |
| An uncontrolled and progressive growth of cells. It may be benign or malignant. same as Tumor. |
|
Neoplastic |
| Pertaining to or like a neoplasm or neoplasia (tumor). |
|
Nephrotoxin |
| A systemic poison whose target is the kidney. |
|
Neurotoxicity |
| Toxicity to cells of the central nervous system (brain and spinal cord) and the peripheral nervous system (nerves outside the CNS). |
|
Neurotoxin |
| A systemic poison whose target organ is the nervous system. |
|
New Drug Application (NDA) |
| The process by which a manufacturer of a new drug applies to the Food and Drug Administration for formal approval to market the drug. |
|
NIOSH |
| National Institute of Occupational Safety and Health. It is an institute in the Public Health Service that conducts research on health hazards in the workplace. |
|
NOAEL |
| No Observed Adverse Effect Level. The highest dose in a toxicity study at which there were no toxic or adverse effects observed. |
|
Non-Clinical Laboratory Study |
| A study of a pharmaceutical performed with laboratory animals which provides the basis for human clinical investigations. |
|
|